Cargando…
Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω
Feline panleukopenia is caused by a small parvovirus (FPV) which is very stable and able to survive for one year at room temperature in organic material on solid fomites. Virtually all susceptible cats are exposed and infected within the first year of life. The acute form is common, with hyperthermi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AFVAC. Published by Elsevier Masson SAS
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148829/ http://dx.doi.org/10.1016/j.anicom.2009.09.001 |
_version_ | 1783520678948896768 |
---|---|
author | Siméon, L.-A. Mercier, P. Mazière, P. Bongrain, G. |
author_facet | Siméon, L.-A. Mercier, P. Mazière, P. Bongrain, G. |
author_sort | Siméon, L.-A. |
collection | PubMed |
description | Feline panleukopenia is caused by a small parvovirus (FPV) which is very stable and able to survive for one year at room temperature in organic material on solid fomites. Virtually all susceptible cats are exposed and infected within the first year of life. The acute form is common, with hyperthermia, depression and anorexia occurring within three to four days before presentation. In most cases, mortality caused by FPV infection can be avoided with appropriate symptomatic therapy and nursing care. However, severe clinical illness associated with bacteraemia is often the rule in young unvaccinated cats and frequently fatal. If a symptomatic therapy is not enough efficient, then it must be quickly associated with antiviral treatment. The feline recombinant interferon omega was used successfully, according to a published protocol design, the status of the cat being monitored before, during and after treatment. |
format | Online Article Text |
id | pubmed-7148829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | AFVAC. Published by Elsevier Masson SAS |
record_format | MEDLINE/PubMed |
spelling | pubmed-71488292020-04-13 Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω Siméon, L.-A. Mercier, P. Mazière, P. Bongrain, G. Pratique Me´dicale & Chirurgicale De L'Animal De Compagnie Cas Clinique Feline panleukopenia is caused by a small parvovirus (FPV) which is very stable and able to survive for one year at room temperature in organic material on solid fomites. Virtually all susceptible cats are exposed and infected within the first year of life. The acute form is common, with hyperthermia, depression and anorexia occurring within three to four days before presentation. In most cases, mortality caused by FPV infection can be avoided with appropriate symptomatic therapy and nursing care. However, severe clinical illness associated with bacteraemia is often the rule in young unvaccinated cats and frequently fatal. If a symptomatic therapy is not enough efficient, then it must be quickly associated with antiviral treatment. The feline recombinant interferon omega was used successfully, according to a published protocol design, the status of the cat being monitored before, during and after treatment. AFVAC. Published by Elsevier Masson SAS 2009 2009-10-16 /pmc/articles/PMC7148829/ http://dx.doi.org/10.1016/j.anicom.2009.09.001 Text en Copyright © 2009 AFVAC. Published by Elsevier Masson SAS All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Cas Clinique Siméon, L.-A. Mercier, P. Mazière, P. Bongrain, G. Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
title | Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
title_full | Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
title_fullStr | Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
title_full_unstemmed | Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
title_short | Panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
title_sort | panleucopénie féline aiguë : à propos d’un cas traité avec succès par l’interféron-ω |
topic | Cas Clinique |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148829/ http://dx.doi.org/10.1016/j.anicom.2009.09.001 |
work_keys_str_mv | AT simeonla panleucopeniefelineaigueaproposduncastraiteavecsuccesparlinterferonō AT mercierp panleucopeniefelineaigueaproposduncastraiteavecsuccesparlinterferonō AT mazierep panleucopeniefelineaigueaproposduncastraiteavecsuccesparlinterferonō AT bongraing panleucopeniefelineaigueaproposduncastraiteavecsuccesparlinterferonō |